Randomized Controlled Trial
Extended-release niacin/laropiprant lipid-altering consistency across patient subgroups.
Int. J. Clin. Pract. 2011 Apr 1;65(4):436-45.
Randomized Controlled Trial
Effects of extended-release niacin with laropiprant in high-risk patients.
N. Engl. J. Med. 2014 Jul 17; 371 (3): 203-12.
Randomized Controlled Trial
Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Clin Ther. 2008 Dec 1;30(12):2298-313.